Transarterial Chemoembolization plus Sorafenib versus Sorafenib Alone in Advanced Hepatocellular Carcinoma (SELECT): A Multicenter, Phase 3, Randomized, Controlled Trial.
Zhao Y, Bai W, Ding R, You N, Zheng L, Li L, Wu J, Zhang P, Huang W, Zhang H, Zhang Y, Zhu D, Li H, Xia D, Yuan J, Li X, Wang Z, Luo B, Guo W, Yin Z, Mu W, Huang M, Li J, Ren W, Fan D, Lv Y, Han G.
Zhao Y, et al. Among authors: huang w.
Liver Cancer. 2025 May 22:1-14. doi: 10.1159/000546530. Online ahead of print.
Liver Cancer. 2025.
PMID: 40585896
Free PMC article.